about
Glucose-6-phosphatase deficiencyNatural history of hepatocellular adenoma formation in glycogen storage disease type ILiver tumors in children with metabolic disordersLiver biopsy in modern clinical practice: a pediatric point-of-viewGlycogen storage disease type I and G6Pase-β deficiency: etiology and therapyThe molecular background of glycogen metabolism disorders.Glycogen storage diseases: new perspectives.Glycogenotic hepatocellular carcinoma with glycogen-ground-glass hepatocytes: a heuristically highly relevant phenotype.Glycogen storage disease type I: pathophysiology of liver adenomas.Epidemiology and carcinogenesis of hepatocellular carcinoma.Historical highlights and unsolved problems in glycogen storage disease type 1.Glycogen storage disease type I: indications for liver and/or kidney transplantation.Guidelines for management of glycogen storage disease type I - European Study on Glycogen Storage Disease Type I (ESGSD I).Regression of hepatocellular adenomas with strict dietary therapy in patients with glycogen storage disease type I.Perioperative management of hemostasis for surgery of benign hepatic adenomas in patients with glycogen storage disease type ia.Benign hepatocellular tumors in children: focal nodular hyperplasia and hepatocellular adenomaMutations in the glucose-6-phosphatase-alpha (G6PC) gene that cause type Ia glycogen storage diseaseNecrotic foci, elevated chemokines and infiltrating neutrophils in the liver of glycogen storage disease type Ia.Normoglycemia alone is insufficient to prevent long-term complications of hepatocellular adenoma in glycogen storage disease type Ib mice.Malignant transformation of hepatocellular adenoma with bone marrow metaplasia arising in glycogen storage disease type I: A case report.Primary malignant liver tumors in children.Liver transplantation for pediatric inherited metabolic disorders: Considerations for indications, complications, and perioperative management.Identification of differentially expressed microRNAs in human hepatocellular adenoma associated with type I glycogen storage disease: a potential utility as biomarkers.Differential role of hepatocyte nuclear factor-1 in the regulation of glucose-6-phosphatase catalytic subunit gene transcription by cAMP in liver- and kidney-derived cell lines.Hepatocellular carcinoma and focal nodular hyperplasia of the liver in a glycogen storage disease patient.Oral giant cell granuloma in a patient with glycogen storage disease.Effect of continuous glucose therapy with uncooked cornstarch on the long-term clinical course of type 1a glycogen storage disease.Stereotactic radiofrequency ablation for liver tumors in inherited metabolic disorders.Contrast-enhanced ultrasonography in patients with glycogen storage disease type Ia and adenomas.Current status of hepatic glycogen storage disease in Japan: clinical manifestations, treatments and long-term outcomes.Glycogen storage disease type I: diagnosis, management, clinical course and outcome. Results of the European Study on Glycogen Storage Disease Type I (ESGSD I).Glycogen storage disease type Ia in two littermate Maltese puppies.Hepatocyte specific expression of an oncogenic variant of β-catenin results in lethal metabolic dysfunction in mice.Hepatocellular adenoma in glycogen storage disorder type I: a clinicopathological and molecular study.Pediatric hepatocellular carcinoma
P2860
Q21202870-0956FDA9-C683-41FA-A9DD-6FF7985305B5Q24633522-D6F1AA5A-CCA6-48F6-942B-7FB80AEF38B5Q26770292-1D3B97D8-2305-4ABD-B797-0A3040606357Q26826920-DF095B0C-E1AA-4C88-9A28-994B49A4940BQ28296663-4618B8B1-1A23-4FE4-9645-9456C78BC492Q30326827-B7A9B684-8627-4E35-AE9B-0CBA6FA4301DQ34098766-E2C7292A-6816-44EF-845B-99CFBC16F478Q34512175-91B3A28C-D1D8-4563-BC55-802445D69D29Q34528044-8C4D1059-0F7C-4213-8477-1CF9F3734175Q34589304-CB399E62-EC9D-456F-8610-CD69E50B0413Q34954560-BEEA6F31-F3CC-4B31-8692-DAF8055934D5Q34954595-D98DEB41-9474-4D10-8133-68DB2F3B330DQ34954705-B5A39035-BAE4-4492-898E-766155586432Q35183122-F836C234-25CD-49D6-8152-6AE4AC025978Q36433240-C5821DF3-66D5-44A5-B294-9AFDA66CC28BQ36716800-A5FFC568-601F-4566-B4C8-7144D901D3F3Q36777763-8BCD995B-586E-455B-B9C8-7A5E7D2584A7Q37348313-ADE066A2-648A-441F-8785-1C924C0EF318Q37387718-0536BA60-92FC-4DC7-816C-C26FF4C481FCQ37406790-6F8057E0-36C5-489C-A809-CFB6B9623CE3Q37989814-B8500933-2547-43F9-BB67-512FFB558E33Q38872573-DE33ACDA-8F54-4493-B790-146BFBC57EB8Q39078029-B60619C4-2693-4EB3-845E-51AAB444CFF5Q40886678-3AE22DD2-DF15-4779-8788-B4905EF60AE9Q42222658-7B24152E-F813-44A7-91F6-A5A959424294Q43098324-88B82692-B69B-40FF-8125-BE92E865283DQ44175104-27EF4B56-230A-493E-9766-327F8C8836E2Q45183031-A9D70AC5-01A3-40F0-9B15-C4C3FB8B76D9Q46195729-C3235CE1-0A5F-4BAD-B75D-9F2AECF02138Q46210619-5DEC4D10-032B-4444-9D59-9011BBE0ADA8Q51952874-B9D95C67-FAF3-4D42-9392-D1B88438E093Q52013705-CCF0B0B0-08DD-480E-880E-131818B6756AQ52726477-8503CC8B-3BEA-46EA-8808-871C060651C2Q53654697-0454E864-D7A4-4BE5-B5AD-2235507DAB2AQ58707831-2FD30EF2-5677-4EB6-8B02-FB0F8DC1441E
P2860
description
1993 nî lūn-bûn
@nan
1993 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1993 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1993年の論文
@ja
1993年論文
@yue
1993年論文
@zh-hant
1993年論文
@zh-hk
1993年論文
@zh-mo
1993年論文
@zh-tw
1993年论文
@wuu
name
Glycogen storage disease I and hepatocellular tumours.
@ast
Glycogen storage disease I and hepatocellular tumours.
@en
Glycogen storage disease I and hepatocellular tumours.
@nl
type
label
Glycogen storage disease I and hepatocellular tumours.
@ast
Glycogen storage disease I and hepatocellular tumours.
@en
Glycogen storage disease I and hepatocellular tumours.
@nl
prefLabel
Glycogen storage disease I and hepatocellular tumours.
@ast
Glycogen storage disease I and hepatocellular tumours.
@en
Glycogen storage disease I and hepatocellular tumours.
@nl
P356
P1476
Glycogen storage disease I and hepatocellular tumours.
@en
P2093
P2888
P304
P356
10.1007/BF02072092
P478
152 Suppl 1
P577
1993-01-01T00:00:00Z
P6179
1016697406